Aβ Immunotherapy: Lessons Learned for Potential Treatment of Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1660-2862|2|5|255-260

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.2, Iss.5, 2006-02, pp. : 255-260

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intraneuronal Aβ Accumulation, Amyloid Plaques, and Synapse Pathology in Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 10, Iss. 1-4, 2012-01 ,pp. : 56-59

Karger

Access to resources Recommend Favorite

Lithium, a Potential Protective Drug in Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 5, Iss. 3-4, 2008-03 ,pp. : 247-249

Karger

Access to resources Recommend Favorite

Retinoids as a Perspective in Treatment of Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 7, Iss. 1-3, 2010-03 ,pp. : 190-192

Karger

Access to resources Recommend Favorite

Passive Immunization of the Aβ42(43) C-Terminal-Specific Antibody BC05 in a Mouse Model of Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 2, Iss. 1, 2005-08 ,pp. : 36-43

Karger

Access to resources Recommend Favorite

Development of a Novel Yeast Cell-Based System for Studying the Aggregation of Alzheimer’s Disease-Associated Aβ Peptides in vivo

By  

Neurodegenerative Diseases, Vol. 4, Iss. 2-3, 2007-06 ,pp. : 136-147

Karger

Access to resources Recommend Favorite